Literature DB >> 7692955

Choroidal neovascularisation in age-related macular disease.

A C Bird.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 7692955      PMCID： PMC504600          DOI： 10.1136/bjo.77.10.614

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  36 in total

1.  Ageing and degeneration in the macular region: a clinico-pathological study.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

2.  Inhibition of neovascularization by an extract derived from vitreous.

Authors:  I Preis; R Langer; H Brem; J Folkman
Journal:  Am J Ophthalmol       Date:  1977-09       Impact factor: 5.258

3.  Isolations of a cartilage factor that inhibits tumor neovascularization.

Authors:  R Langer; H Brem; K Falterman; M Klein; J Folkman
Journal:  Science       Date:  1976-07-02       Impact factor: 47.728

4.  Lymphocyte-induced corneal neovascularization: a morphologic assessment.

Authors:  R J Epstein; W F Hughes
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-07       Impact factor: 4.799

5.  Pathologic features of senile macular degeneration.

Authors:  W R Green; P J McDonnell; J H Yeo
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

6.  The recurrence of neovascularization and late visual failure in senile disciform lesions.

Authors:  I H Chisholm
Journal:  Trans Ophthalmol Soc U K       Date:  1983

7.  An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane.

Authors:  P Penfold; M Killingsworth; S Sarks
Journal:  Aust J Ophthalmol       Date:  1984-02

8.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. II. Studies on the effect of leukocytic elimination on corneal vascularization.

Authors:  C H Fromer; G K Klintworth
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

9.  The resistance of certain tissues to invasion. II. Evidence for extractable factors in cartilage which inhibit invasion by vascularized mesenchyme.

Authors:  N Sorgente; K E Kuettner; L W Soble; R Eisenstein
Journal:  Lab Invest       Date:  1975-02       Impact factor: 5.662

10.  Retinal pigment epithelial cells release an inhibitor of neovascularization.

Authors:  B M Glaser; P A Campochiaro; J L Davis; M Sato
Journal:  Arch Ophthalmol       Date:  1985-12
View more
  1 in total

1.  Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial.

Authors:  Martijn S Visser; Sankha Amarakoon; Tom Missotten; Reinier Timman; Jan J V Busschbach
Journal:  Qual Life Res       Date:  2020-07-14       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.